Institutional Ownership Kal Vista Pharmaceuticals, Inc. (KALV)
This table provides information about the institutional ownership of Kal Vista Pharmaceuticals, Inc. (KALV). We have compiled data on the 149 institutions that hold shares in the stock, with a total of 54.3 Million shares, which have been reported (via 13F filing form) to have a value of $665 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Vr Adviser, LLC
New York, NY |
Aug 14, 2025 Q2 2025 |
6,728,985
shares
|
$82.4 Million
15.07% of portfolio
|
Q2 2025
Added 0.37%
|
|
|
Suvretta Capital Management, LLC
New York, NY |
Aug 14, 2025 Q2 2025 |
4,955,000
shares
|
$60.7 Million
1.93% of portfolio
|
Q2 2025
Added 0.85%
|
|
|
Tang Capital Management LLC
San Diego, CA |
Aug 14, 2025 Q2 2025 |
4,941,798
shares
|
$60.5 Million
3.35% of portfolio
|
Q1 2025
Added 0.98%
|
|
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
Aug 14, 2025 Q2 2025 |
4,887,867
shares
|
$59.9 Million
2.92% of portfolio
|
Q4 2024
Added 32.54%
|
|
|
Vestal Point Capital, LP
New York, NY |
Aug 14, 2025 Q2 2025 |
4,675,000
shares
|
$57.3 Million
2.78% of portfolio
|
Q2 2025
Reduced 1.61%
|
|
|
Capital World Investors
Los Angeles, CA |
Aug 13, 2025 Q2 2025 |
3,177,587
shares
|
$38.9 Million
0.01% of portfolio
|
Q1 2025
Reduced 5.82%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
2,945,116
shares
|
$36.1 Million
0.0% of portfolio
|
Q2 2024
Added 21.09%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Aug 11, 2025 Q2 2025 |
2,412,399
shares
|
$29.6 Million
0.0% of portfolio
|
Q2 2025
Added 4.95%
|
|
|
Woodline Partners LP
San Francisco, CA |
Aug 14, 2025 Q2 2025 |
1,920,664
shares
|
$23.5 Million
0.12% of portfolio
|
Q2 2025
Added 18.75%
|
|
|
Silverarc Capital Management, LLC
|
Aug 14, 2025 Q2 2025 |
1,832,171
shares
|
$22.4 Million
5.01% of portfolio
|
Q2 2025
Added 7.84%
|
|
|
State Street Corp
Boston, MA |
Aug 14, 2025 Q2 2025 |
1,349,539
shares
|
$16.5 Million
0.0% of portfolio
|
Q2 2025
Added 23.4%
|
|
|
Octagon Capital Advisors LP
New York, NY |
Aug 14, 2025 Q2 2025 |
1,273,333
shares
|
$15.6 Million
5.47% of portfolio
|
Q2 2025
Reduced 7.06%
|
|
|
Emerald Advisers, LLC
|
Aug 04, 2025 Q2 2025 |
1,038,049
shares
|
$12.7 Million
0.46% of portfolio
|
Q2 2025
Added 15.57%
|
|
|
Ameriprise Financial Inc
Minneapolis, MN |
Aug 14, 2025 Q2 2025 |
945,125
shares
|
$11.6 Million
0.0% of portfolio
|
Q2 2025
Added 2258.57%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Aug 08, 2025 Q2 2025 |
941,212
shares
|
$11.5 Million
0.0% of portfolio
|
Q2 2025
Added 2.84%
|
|
|
Emerald Mutual Fund Advisers Trust
|
Aug 04, 2025 Q2 2025 |
768,972
shares
|
$9.42 Million
0.59% of portfolio
|
Q2 2025
Added 26.43%
|
|
|
Parkman Healthcare Partners LLC
Stamford, CT |
Aug 14, 2025 Q2 2025 |
679,063
shares
|
$8.32 Million
1.03% of portfolio
|
Q2 2025
Reduced 9.91%
|
|
|
Dafna Capital Management LLC
Los Angeles, CA |
Aug 14, 2025 Q2 2025 |
581,757
shares
|
$7.13 Million
1.91% of portfolio
|
Q2 2025
Reduced 22.68%
|
|
|
Schroder Investment Management Group
London, X0 |
Aug 13, 2025 Q2 2025 |
554,958
shares
|
$6.8 Million
0.01% of portfolio
|
Q2 2025
Reduced 36.07%
|
|
|
Jpmorgan Chase & CO
New York, NY |
May 12, 2025 Q1 2025 |
402,504
shares
|
$4.93 Million
0.0% of portfolio
|
Q1 2025
Added 1793.25%
|
|
|
Stem Point Capital LP
New York, NY |
Aug 14, 2025 Q2 2025 |
386,790
shares
|
$4.74 Million
1.4% of portfolio
|
Q2 2025
Reduced 0.01%
|
|
|
Bank Of America Corp
Charlotte, NC |
Aug 14, 2025 Q2 2025 |
366,966
shares
|
$4.5 Million
0.0% of portfolio
|
Q2 2025
Added 19.05%
|
|
|
Northern Trust Corp
Chicago, IL |
Aug 13, 2025 Q2 2025 |
352,152
shares
|
$4.31 Million
0.0% of portfolio
|
Q2 2025
Reduced 9.14%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Aug 14, 2025 Q2 2025 |
340,629
shares
|
$4.17 Million
0.0% of portfolio
|
Q2 2025
Added 71.86%
|
|
|
Great Point Partners LLC
Greenwich, CT |
Aug 14, 2025 Q2 2025 |
323,170
shares
|
$3.96 Million
3.03% of portfolio
|
Q2 2025
Reduced 68.14%
|